Cargando…

Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk

AIMS/HYPOTHESIS: Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK), glucokinase regulatory protein (GCKR), islet-specific glucose 6 phos...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiling, E., van ’t Riet, E., Groenewoud, M. J., Welschen, L. M. C., van Hove, E. C., Nijpels, G., Maassen, J. A., Dekker, J. M., ’t Hart, L. M.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723681/
https://www.ncbi.nlm.nih.gov/pubmed/19533084
http://dx.doi.org/10.1007/s00125-009-1413-9
_version_ 1782170372345430016
author Reiling, E.
van ’t Riet, E.
Groenewoud, M. J.
Welschen, L. M. C.
van Hove, E. C.
Nijpels, G.
Maassen, J. A.
Dekker, J. M.
’t Hart, L. M.
author_facet Reiling, E.
van ’t Riet, E.
Groenewoud, M. J.
Welschen, L. M. C.
van Hove, E. C.
Nijpels, G.
Maassen, J. A.
Dekker, J. M.
’t Hart, L. M.
author_sort Reiling, E.
collection PubMed
description AIMS/HYPOTHESIS: Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK), glucokinase regulatory protein (GCKR), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2) and melatonin receptor type 1B (MTNR1B) is associated with FPG. In this study we examined whether these loci also contribute to type 2 diabetes susceptibility. METHODS: A random selection from the Dutch New Hoorn Study was used for replication of the association with FGP (2,361 non-diabetic participants). For the genetic association study we extended the study sample with 2,628 participants with type 2 diabetes. Risk allele counting was used to calculate a four-gene risk allele score for each individual. RESULTS: Variants of the GCK, G6PC2 and MTNR1B genes but not GCKR were associated with FPG (all, p ≤ 0.001; GCKR, p = 0.23). Combining these four genes in a risk allele score resulted in an increase of 0.05 mmol/l (0.04–0.07) per additional risk allele (p = 2 × 10(−13)). Furthermore, participants with less than three or more than five risk alleles showed significantly different type 2 diabetes susceptibility compared with the most common group with four risk alleles (OR 0.77 [0.65–0.93], p = 0.005 and OR 2.05 [1.50–2.80], p = 4 × 10(−6) respectively). The age at diagnosis was also significantly associated with the number of risk alleles (p = 0.009). CONCLUSIONS: A combined risk allele score for single-nucleotide polymorphisms in four known FPG loci is significantly associated with FPG and HbA(1c) in a Dutch population-based sample of non-diabetic participants. Carriers of low or high numbers of risk alleles show significantly different risks for type 2 diabetes compared with the reference group. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-009-1413-9) contains supplementary material, which is available to authorised users.
format Text
id pubmed-2723681
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-27236812009-08-10 Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk Reiling, E. van ’t Riet, E. Groenewoud, M. J. Welschen, L. M. C. van Hove, E. C. Nijpels, G. Maassen, J. A. Dekker, J. M. ’t Hart, L. M. Diabetologia Article AIMS/HYPOTHESIS: Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK), glucokinase regulatory protein (GCKR), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2) and melatonin receptor type 1B (MTNR1B) is associated with FPG. In this study we examined whether these loci also contribute to type 2 diabetes susceptibility. METHODS: A random selection from the Dutch New Hoorn Study was used for replication of the association with FGP (2,361 non-diabetic participants). For the genetic association study we extended the study sample with 2,628 participants with type 2 diabetes. Risk allele counting was used to calculate a four-gene risk allele score for each individual. RESULTS: Variants of the GCK, G6PC2 and MTNR1B genes but not GCKR were associated with FPG (all, p ≤ 0.001; GCKR, p = 0.23). Combining these four genes in a risk allele score resulted in an increase of 0.05 mmol/l (0.04–0.07) per additional risk allele (p = 2 × 10(−13)). Furthermore, participants with less than three or more than five risk alleles showed significantly different type 2 diabetes susceptibility compared with the most common group with four risk alleles (OR 0.77 [0.65–0.93], p = 0.005 and OR 2.05 [1.50–2.80], p = 4 × 10(−6) respectively). The age at diagnosis was also significantly associated with the number of risk alleles (p = 0.009). CONCLUSIONS: A combined risk allele score for single-nucleotide polymorphisms in four known FPG loci is significantly associated with FPG and HbA(1c) in a Dutch population-based sample of non-diabetic participants. Carriers of low or high numbers of risk alleles show significantly different risks for type 2 diabetes compared with the reference group. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-009-1413-9) contains supplementary material, which is available to authorised users. Springer-Verlag 2009-06-17 2009-09 /pmc/articles/PMC2723681/ /pubmed/19533084 http://dx.doi.org/10.1007/s00125-009-1413-9 Text en © The Author(s) 2009
spellingShingle Article
Reiling, E.
van ’t Riet, E.
Groenewoud, M. J.
Welschen, L. M. C.
van Hove, E. C.
Nijpels, G.
Maassen, J. A.
Dekker, J. M.
’t Hart, L. M.
Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
title Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
title_full Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
title_fullStr Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
title_full_unstemmed Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
title_short Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
title_sort combined effects of single-nucleotide polymorphisms in gck, gckr, g6pc2 and mtnr1b on fasting plasma glucose and type 2 diabetes risk
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723681/
https://www.ncbi.nlm.nih.gov/pubmed/19533084
http://dx.doi.org/10.1007/s00125-009-1413-9
work_keys_str_mv AT reilinge combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk
AT vantriete combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk
AT groenewoudmj combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk
AT welschenlmc combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk
AT vanhoveec combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk
AT nijpelsg combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk
AT maassenja combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk
AT dekkerjm combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk
AT thartlm combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk